Eugeroic


Eugeroics, also known as wakefulness-promoting agents and wakefulness-promoting drugs, are a class of drugs that promote wakefulness and alertness. They are medically indicated for the treatment of certain sleep disorders including excessive daytime sleepiness in narcolepsy or obstructive sleep apnea. They generally have a very low addictive potential. Eugeroics are also often prescribed off-label for the treatment of EDS in idiopathic hypersomnia, a rare and often debilitating sleep disorder which currently has no official treatments approved by the Food and Drug Administration.
Modafinil and armodafinil each act as a selective, weak, atypical dopamine reuptake inhibitor whereas adrafinil acts as a prodrug for modafinil. Other eugeroics include solriamfetol, which acts as a norepinephrine–dopamine reuptake inhibitor, and pitolisant, which acts as a histamine 3 receptor antagonist/inverse agonist.

Examples

Marketed